苑東生物(688513.SH):董事長不再兼任總經理 聘任袁明旭為總經理
格隆匯 12 月 31日丨苑東生物(688513.SH)公佈,基於公司經營管理和長遠發展戰略考慮,公司董事長兼總經理王穎於近日向董事會遞交書面辭職報吿,申請辭去公司總經理職務,該報吿自送達董事會之日起生效。辭職後,王穎繼續擔任公司董事長及董事會提名委員會委員。
王穎作為公司創始人,長年擔任公司董事長兼總經理,任期內公司業績穩健增長、行業地位逐步提升,並於2020 年9月2日成功登陸科創板上市交易。公司董事會對王穎在擔任總經理期間所做出的貢獻表示衷心的感謝!王穎辭去公司總經理職務後,將更加專注於公司整體發展戰略佈局、新業務拓展、業務佈局整合、企業文化傳承與發展等工作,符合公司發展戰略,也符合公司和全體股東的利益。
經公司董事長王穎提名,董事會提名委員會審查,公司第二屆董事會第十五次會議決議同意聘任袁明旭為公司總經理,全面負責公司戰略的落地和日常經營管理工作。袁明旭的任期自本次董事會聘任通過之日起至本屆董事會屆滿,任期屆滿可連聘連任。
袁明旭作為公司創始團隊成員之一,具有豐富醫藥企業經營管理經驗,擔任公司總經理,有利於提高公司管理水平和運營效率,進一步提升公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.